Application 211869
- Type
- ANDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ISOSULFAN BLUE | ISOSULFAN BLUE | INJECTABLE;INJECTION | 1% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211869-001 | ISOSULFAN BLUE | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A211869-001 | ISOSULFAN BLUE | 1% | INJECTABLE / INJECTION | 2022-09-08 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A211869-001 | ISOSULFAN BLUE | 1% | INJECTABLE / INJECTION | 2022-09-08 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A211869-001 | ISOSULFAN BLUE | 1% | INJECTABLE / INJECTION | 2022-09-08 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A211869-001 | ISOSULFAN BLUE | 1% | INJECTABLE / INJECTION | 2022-09-08 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A211869-001 | ISOSULFAN BLUE | 1% | INJECTABLE / INJECTION | 2022-09-08 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A211869-001 | ISOSULFAN BLUE | 1% | INJECTABLE / INJECTION | 2022-09-08 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A211869-001 | ISOSULFAN BLUE | 1% | INJECTABLE / INJECTION | 2022-09-08 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A211869-001 | ISOSULFAN BLUE | 1% | INJECTABLE / INJECTION | 2022-09-08 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A211869-001 | ISOSULFAN BLUE | 1% | INJECTABLE / INJECTION | 2022-09-08 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A211869-001 | ISOSULFAN BLUE | 1% | INJECTABLE / INJECTION | 2022-09-08 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A211869-001 | ISOSULFAN BLUE | 1% | INJECTABLE / INJECTION | 2022-09-08 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A211869-001 | ISOSULFAN BLUE | 1% | INJECTABLE / INJECTION | AP | 2022-09-08 | f41ea6bd6efb… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211869-001 | ISOSULFAN BLUE | 50MG/5ML (10MG/ML) | SOLUTION / SUBCUTANEOUS | 2022-09-08 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A211869-001 | AP | 1 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Isosulfan Blue | ISOSULFAN BLUE | Devatis, Inc. | aa6260da-0acd-4552-a215-07df8da1031c | 2026-07-01 | Warnings, Adverse reactions | Isosulfan Blue ISOSULFAN BLUE |
| Isosulfan Blue | ISOSULFAN BLUE | Somerset Therapeutics, LLC | a4c7400a-ff36-4a76-aa84-7f91e303f937 | 2026-06-24 | Warnings, Adverse reactions | Isosulfan Blue ISOSULFAN BLUE |
| Isosulfan blue | ISOSULFAN BLUE | Novadoz Pharmaceuticals LLC | 4b7e84ee-f3ba-4b80-86d3-f4debe6a2eca | 2026-04-29 | Warnings, Adverse reactions | Isosulfan blue ISOSULFAN BLUE |
| Isosulfan Blue | ISOSULFAN BLUE | Eugia US LLC | 42f2d62a-c7f2-4706-87bc-64f3e72d63a9 | 2026-02-20 | Warnings, Adverse reactions | Isosulfan Blue ISOSULFAN BLUE |
| Isosulfan Blue | ISOSULFAN BLUE | Mylan Institutional LLC | 0391e544-3633-48df-9f3a-ed16183125b1 | 2025-12-15 | Warnings, Adverse reactions | Isosulfan Blue ISOSULFAN BLUE |
| Isosulfan Blue | ISOSULFAN BLUE | Mylan Institutional LLC | 1878964e-5220-48c8-a872-dcadbc451aff | 2025-12-15 | Warnings, Adverse reactions | Isosulfan Blue ISOSULFAN BLUE |
| Isosulfan Blue | ISOSULFAN BLUE | Eugia US LLC | 61b48ff8-7ace-4ab7-9f58-f250e2830d16 | 2024-02-15 | Warnings, Adverse reactions | Isosulfan Blue ISOSULFAN BLUE |
| Isosulfan Blue | ISOSULFAN BLUE | Meitheal Pharmaceuticals Inc. | d36ae5af-6351-497a-9151-82bcb2c62fa0 | 2021-10-12 | Warnings, Adverse reactions | Isosulfan Blue ISOSULFAN BLUE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.